BX LAB TECHNICAL ARTICLE
Arrowhead's P=S Detour to a 5′-Cyclopropyl Phosphonate
A failed cyclopropanation did not kill the route. A temporary P=S substitution changed the electronics long enough to close the ring, after which the synthesis returned to P=O.
Key takeaways
The original vinyl phosphonate accepted the sulfur ylide but stalled at a persistent 1,4-addition intermediate.
A thiophosphonate ylide enabled the Corey-Chaykovsky step in 65% yield, although the product emerged as a 3:2 diastereomeric mixture.
Crystallization delivered a single diastereomer, but the 28% P=S-to-P=O oxidation and uridine-only scope remain important limitations.
Why this is more than a protecting-group route
A 5′ phosphate is part of how an RNA interference guide strand is recognized, but an exposed phosphate is also vulnerable to enzymatic loss. Arrowhead's cyclopropyl phosphonate was designed as a non-cleavable phosphate mimic at that terminus. The 2021 Chemical Communications paper does not describe a finished drug. It describes the harder upstream problem: making a protected, 5′-modified uridine building block that can enter phosphoramidite-based oligonucleotide synthesis.
The first cyclopropanation stopped halfway
The team reached an E-vinyl phosphonate from 2′-O-methyluridine through silyl protection, selective 5′ deprotection, oxidation and olefination. Simmons-Smith conditions and other carbene approaches either did nothing useful or decomposed the substrate. Corey-Chaykovsky conditions consumed the vinyl phosphonate, but the expected cyclopropane did not appear. The crude proton NMR was consistent with addition across the alkene while retaining the uracil signals. The authors proposed a 1,4-addition intermediate whose phosphonate-stabilized carbanion would not complete ring closure.
P=S was a temporary electronic adjustment
Rather than force the same substrate through harsher conditions, the route changed the substrate. A new thiophosphonate ylide was prepared and used without isolating a perfectly clean reagent. The aldehyde intermediate, generated by DMP oxidation, was taken directly into olefination to give the E-vinyl thiophosphonate. In the authors' mechanistic reading, replacing P=O with P=S altered stabilization of the addition intermediate enough for the second bond-forming event to occur. The sulfur was a route-enabling device, not the final functional group.
The ring closed; selectivity still had to be earned
The Corey-Chaykovsky reaction then gave the cyclopropyl thiophosphonate in 65% yield and 3:2 diastereomeric ratio. The reported crude NMR did not show the N-methylated or uracil-cyclopropanated products that had been plausible side reactions. After removal of the 3′ silyl group, Oxone oxidized P=S back to P=O. That step returned only 28% yield. The chemistry had solved ring formation, but it had not solved the whole process.
The most scalable operation was crystallization
The oxidized alcohol could be crystallized. An ethyl acetate slurry enriched the major diastereomer from 3:2 to above 90%, and an ethanol-heptane recrystallization delivered a single diastereomer. X-ray analysis assigned the cyclopropyl stereochemistry. That isolation sequence matters as much as the reaction design: it replaces a difficult chromatographic separation with operations that have a clearer path to larger batches. A final phosphitylation produced the oligonucleotide building block as a 1:1 mixture at the newly introduced phosphorus center.
What the paper does not establish
The published route demonstrates one protected uridine series. It does not show that adenine, guanine and cytosine substrates will tolerate the same oxidation, olefination, cyclopropanation and isolation sequence. It also leaves a conspicuous low-yield oxidation and does not report an asymmetric ring-forming step. Patent knockdown data support interest in the modification, but they should not be read as a general biological comparison for every sequence or target. Those are development questions, not details to smooth over in a route summary.
What to define before sourcing the building block
A useful request should state the nucleobase, 2′ substitution, remaining hydroxyl protection, absolute configuration at the cyclopropyl unit and whether the final phosphoramidite phosphorus center may be supplied as a diastereomeric mixture. The specification should separate chemical purity from diastereomeric purity and identify the methods used for both. Water, residual oxidant-derived inorganic species, storage temperature and solution stability matter because the material still has to behave as a phosphoramidite on an oligonucleotide synthesizer, not merely give a clean mass spectrum.
References
Technical context is supported by the peer-reviewed literature below.